Research published in journals like Diabetes Care has consistently shown that people with diabetes are two to four times more likely to develop PAD than those without
Ozempic, Wegovy, Zepbound, Mounjaro-the names get thrown around like theyre interchangeable, and thats usually where the confusion starts
Plus, it is non-GMO and gluten-free, making it accessible for various dietary preferences
52 Although dementia was not a primary outcome, a pooled analysis of 15,820 patients with type 2 diabetes randomised to GLP-1 receptor agonist treatment or placebo found a 50% reduction in dementia progression over a median of 3.6 years (15 cases in the placebo group vs 32 in the GLP-1 receptor agonist group)
Fatty liver disease, medically termed hepatic steatosis, occurs when excess fat accumulates in liver cells